Access Programs Designed for Care, Compliance, and Continuity
Patients in need can’t wait for health systems to catch up. Our Managed Access Programs (MAPs) provide structured, compliant solutions that help bring critical therapies to patients when conventional commercial channels are not yet in place.
From Compassionate Use to country-specific Early Access models. Every program is designed around the therapy’s context and built with the patient at its center, delivering access that is secure, sustainable and compliant.
Whether supporting first-in-class therapies, orphan drugs, or re-entry after market withdrawal, our MAPs bridge the gap between clinical development and real-world availability. These sponsor-driven programs deliver an integrated access solution. We orchestrate the process by aligning regulatory requirements, country-specific distribution, stakeholder engagement, and education for both patients and providers.
By building trust through structure and accelerating access with care, we help patients access treatment sooner and enable sponsors to move forward with confidence.
We design Managed Access Programs that deliver early patient access while protecting compliance, trust, and long-term market readiness.
About Managed Access Programs
Our Managed Access Programs are designed to navigate the complexities of providing therapies to patients outside of standard commercial channels.
By addressing regulatory, and logistical challenges, our MAPs help pharma and biotech companies expand access to treatments, especially for rare and advanced conditions. Each program is customized to meet the unique needs of therapies, patient populations, and healthcare systems.
Patient-First, Compliance-Driven
Structured access programs built around patient safety and regulatory rigor, aligned with GxP standards at both global and local levels.Early Market Familiarity
Healthcare providers, institutions, and regulatory authorities can gain experience with the therapy prior to full launch, building trust and laying the groundwork for adoption.Real-World Insight and Evidence Readiness
When appropriate, our MAPs can enable structured feedback or real-world data collection.End-to-End Operational Execution
We provide full-service execution, including QP oversight, Importer of Record, pharmacovigilance, and reliable last-mile delivery.Therapy-Aligned Program Design
Each MAP is carefully adapted to the specific needs of the therapy, taking into account its clinical profile, risk landscape, and the realities of national healthcare systems.
Our Managed Access Programs Services
Why Komtur?
One Platform, Integrated Access
We orchestrate regulatory, operational, stakeholder, and medical functions to deliver Early Access, Compassionate Use, and Patient Support services in one patient-centric solution.
Lifecycle Continuity from Clinical to Commercial
Our models support access from first patient supply through to commercialization. This enables agile launch sequencing and consistent patient continuity across stages.
Global Reach with Local Adaptation
With 17 affiliates and deep regional expertise, we tailor implementation country by country. This helps ensure local realities don’t become global bottlenecks.
Trusted in Complex Access Environments
Pharma, Biotech and rare disease innovators rely on Komtur to bridge stakeholder and patient needs with operational access, even when evidence is limited or infrastructure is fragmented.
Supporting the Full Patient Journey beyond Access
Our Patient Support Programs deliver education, coordination, and care continuity. We help patients continue to benefit from therapy while reinforcing outcomes and long-term treatment success.
Design your Managed Access Program
Let’s design a Managed Access Program that delivers safely, compliantly, and with care. Partner with Komtur to turn access goals into patient realities.
“Early access isn’t just about making therapies available. It’s about building programs physicians trust and regulators accept.”
Related Market Access Solutions
Market Access ConsultingShaping access strategies for real-world success. We help translate market access strategies into operational reality. We advise on access model design, stakeholder engagement, distribution frameworks, and compliance infrastructure tailored to each product and region.
Patient Support ProgramEnabling continuity of care. Our tailored programs support patients throughout the treatment journey, from education and onboarding to coordination with healthcare providers and home care services. Designed in collaboration, our solutions are compliant, scalable, and always patient-focused.